CTC-AE+

The adverse event logger

Разработчик: Arpacore
Скачивания
Доход

Описание

CTC-AE+ is a browsable reference to the CTC-AE list of adverse event (AE) terms commonly encountered in oncology, plus a portable Adverse Event Logger to keep track of all adverse events during a clinical study.
The CTC-AE 4 and CTC-AE 5 have been developed from the earlier vocabulary known as CTC (Common Toxicity Criteria). Each AE term is defined and accompanied by a grading scale that indicates the severity of the adverse event. All AE terms are organized by the System Organ Classes (SOCs) defined by the Medical Dictionary for Regulatory Activities (MedDRA).
Adverse events are common phenomena affecting patients being treated for cancer. With the availability of new agents and the multimodality interventions, it is critical to monitor systematically the AEs that are linked to oncology research.
CTCAE is fundamentally intended to be an agreed upon terminology for the designation, reporting, and grading of AEs that occur in oncology research.
########################
CTC-AE serves several purposes
########################
- To standardize AE reporting within the NCI oncology research community, across groups and modalities.
- To facilitate the evaluation of new cancer therapies, treatment modalities, and supportive measures.
- To aid in AE recognition and severity grading.
- To monitor safety data and for regulatory reporting.
- To define oncology research protocol parameters (e.g., eligibility criteria; dose-limiting toxicity; maximum tolerated dose; dose modification).
########################
KARNOFSKY and ECOG
########################
Additionally, CTC-AE+ now includes the two most common performance scores. As a reference and as a guided algorithm when necessary to add the event to the patient's record.
########################
ADVERSE EVENT LOGGER
########################
The Adverse Event Logger is a structured local database to help the investigator to keep track of all the adverse events related to the patients participating in a clinical trial.
It is possible to track multiple clinical studies, multiple patients per clinical trial and multiple events per patient. Events can be selected from the CTC-AE 4 and CTC-AE 5 databases, from Karnofsky and ECOG score tables or can be entered as customized events.
For convenience, all data can be exported as an excel CSV file to be imported into other analysis software.
########################
IMPORTANT NOTE
########################
This application is strictly EU GDPR compliant and no clinical study or patient information is saved outside the device or uploaded to any remote cloud resources.
Скрыть Показать больше...

Встроенные покупки

Adverse Event Logger
€3.99

Скриншоты

CTC-AE+ Частые Вопросы

  • Приложение CTC-AE+ бесплатное?

    Да, CTC-AE+ можно скачать бесплатно, однако в приложении есть встроенные покупки или подписки.

  • Является ли CTC-AE+ фейковым или мошенническим?

    Недостаточно отзывов для надежной оценки. Приложению нужно больше отзывов пользователей.

    Спасибо за ваш голос

  • Сколько стоит CTC-AE+?

    CTC-AE+ имеет несколько покупок/подписок внутри приложения, средняя цена покупки составляет €3.99.

  • Сколько зарабатывает CTC-AE+?

    Чтобы получить оценку дохода приложения CTC-AE+ и другие данные AppStore, вы можете зарегистрироваться на платформе мобильной аналитики AppTail.

Оценки пользователей
Приложение еще не оценено в Ирландия.
История оценок

CTC-AE+ Отзывы Пользователей

App doesn’t work

2muchsauc3804 on

Соединенные Штаты

Don’t bother with this app. It just stays on loading screen forever

Great concept, but needs work

ISM143 on

Соединенные Штаты

Sadly, poorly designed. Can’t save favorites and search terms are tedious. For example, can’t just search ALT- you have to spell it out. Great concept to have CTC-AE 4 and 5 in one app with performance scales, but please make it more user friendly! For an app that costs 2.99, should be bettter.

Search doesn’t work for titles

Jness09 on

Соединенные Штаты

Edit 2019. Revising as promised due to developer response. Search “dyspnea”, nothing comes up. “Breath” and dyspnea will show as a search result. Same with fever and most of the AEs I search for. Make titles of the AE terms somehow searchable and I will revise to 5 stars. Until then I’m looking for a different app.

Needs more

Jkap123 on

Соединенные Штаты

The blood disorders section leaves out thrombocytopenia and leukopenia, for example.

Interesting app

JAG11111 on

Соединенные Штаты

An interesting and easy to use app. Perhaps adding in more adverse event definitions would be helpful, such as thrombocytopenia and leukopenia.

Add search tab 4 iPad!

Add search on

Соединенные Штаты

Please add search capacity for iPad.

great!

beansy34 on

Соединенные Штаты

so much better than carrying around the "not so little" notebook versions. any chance on getting ecog and karnofsky performance scals also?

Excellent program

Oncology MD on

Соединенные Штаты

As a clinical researcher, I find this program to be a great substitute for the usual spiral notebook!

Оценки

История позиций в топах
История рейтингов пока не доступна
Позиции в категории
Рейтинг
Категория
Позиция
Топ платных
38
Топ платных
74
Топ платных
78
Топ платных
81
Топ платных
99

CTC-AE+ Конкуренты

Name
MDBrief
Quickly review Eczema research
Immuno-Oncology
from @ Point of Care™
InflaMed
chronic inflammation
Breast Cancer [BC]
From @Point of Care
CTCAE - Terminology 4.03
Therapy Protocols
and Targeted Therapies
My Running Tracker
Plan. Track, Stats
HARMAN RCP
OncAmigo
TrialKit Coder

CTC-AE+ Доходы и Загрузки

Получите ценные инсайты о производительности CTC-AE+ с помощью нашей аналитики.
Зарегистрируйтесь сейчас, чтобы получить доступ к статистика загрузок и доходов и многому другому.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.